P2Y12 inhibitor versus aspirin monotherapy for secondary prevention of cardiovascular events: meta-analysis of randomized trials.
Aggarwal D, Bhatia K, Chunawala ZS, Furtado RHM, Mukherjee D, Dixon SR, Jain V, Arora S, Zelniker TA, Navarese EP, Mishkel GJ, Lee CJ, Banerjee S, Bangalore S, Levisay JP, Bhatt DL, Ricciardi MJ, Qamar A.
Aggarwal D, et al. Among authors: dixon sr.
Eur Heart J Open. 2022 Mar 21;2(2):oeac019. doi: 10.1093/ehjopen/oeac019. eCollection 2022 Mar.
Eur Heart J Open. 2022.
PMID: 35919116
Free PMC article.